About Sylphid Analytics

Sylphid Analytics is a global provider of specialized services to the pharmaceutical industry, offering high-quality, practical, responsive, and cost-effective solutions to support biotechnology and pharmaceutical companies. From Phase I to IV clinical trials, we expedite the development of life-saving drugs and devices, focusing on adaptability, quality, and efficiency throughout. Our commitment to excellence ensures that every client experiences complete confidence in our staff's knowledge, abilities, and reliability, witnessing clear benefits and results from our involvement in their projects. By supporting clients who facilitate the acceleration of drug approvals to market, we contribute to creating a safer and better world, shaping a brighter future for all.
Sylphid unlocks the full potential of scientific endeavors through customized global partnerships, offering bespoke solutions across the drug development life cycle. Committed to results, we provide resources, expertise, and knowledge exchange, ensuring optimal decisions for impactful outcomes. Our mission is to enhance clinical research experience, emphasizing ethical standards, and performance excellence. Guided by core values of trust, quality, and flexibility, we prioritize high standards, navigating clinical research complexities with adaptability.

As your committed partners, we collaborate to drive discoveries, consult, and plan for every step of developing and testing medical therapies. Choose Sylphid for innovative methodologies, analytical technologies, cost-effectiveness, and operational excellence in drug development – a partnership dedicated to supporting your success in the ever-evolving landscape of modern medicine.
Key Points:

▣ Our offices are headquartered in Hyderabad, India, and located in Reading, United Kingdom.

▣ Our services include Biostatistics, Data Management, Statistical Programming, Medical Writing, Pharmacovigilance, Safety, and Regulatory Affairs.

▣ Our management team has combined experience of over 150 years.

▣ We operate under a project-based and Functional Service Provider (FSP) model.

▣ We have a team of more than 40 professionals.

▣ We are debt-free and privately held.

▣ We support Phase I to Phase IV trials.

▣ In the last 3 years, we have successfully completed more than 50 studies.

▣ Our collective experience includes working on 700+ studies.